Vestmark Advisory Solutions Inc. Has $742,000 Stock Position in Cigna Group $CI

Vestmark Advisory Solutions Inc. lifted its stake in shares of Cigna Group (NYSE:CI) by 239.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,244 shares of the health services provider’s stock after purchasing an additional 1,582 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in Cigna Group were worth $742,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CI. Flaharty Asset Management LLC bought a new position in Cigna Group in the first quarter worth approximately $28,000. 1248 Management LLC bought a new position in shares of Cigna Group in the first quarter valued at approximately $29,000. Solstein Capital LLC purchased a new position in shares of Cigna Group during the second quarter valued at approximately $29,000. Activest Wealth Management grew its holdings in Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after buying an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC purchased a new stake in Cigna Group in the 2nd quarter valued at $30,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Performance

Shares of CI opened at $267.82 on Wednesday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The stock’s 50-day simple moving average is $291.71 and its 200 day simple moving average is $302.28. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The stock has a market capitalization of $71.54 billion, a price-to-earnings ratio of 14.62, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period in the prior year, the business posted $7.51 earnings per share. The company’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Analyst Upgrades and Downgrades

CI has been the subject of a number of recent analyst reports. Wells Fargo & Company reduced their price objective on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 5th. Guggenheim cut their target price on Cigna Group from $350.00 to $309.00 in a research note on Friday, October 31st. Deutsche Bank Aktiengesellschaft decreased their price target on Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Cowen reiterated a “buy” rating on shares of Cigna Group in a research note on Tuesday, November 4th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $339.73.

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.